Drug Prices: The Real Cost of Government Intervention
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
Drug Prices: The Real Cost of Government Intervention
-
ナレーター：
-
著者：
In this episode of the Health Policy Podcast, host Brian Hyde speaks with Eric Maus, Director of Health and Science Policy at Citizens Against Government Waste. They delve into the complex landscape of prescription drug pricing in America, discussing how federal programs like 340B and provisions within the Inflation Reduction Act (IRA) have impacted costs and access. Moss reveals that despite initial projections of savings, the IRA's drug pricing controls are now estimated to cost $700 billion, driving up monthly drug costs for seniors. The conversation also explores the historical ineffectiveness of price controls and the benefits of a free-market approach for pharmaceutical innovation. Additionally, Maus highlights a bipartisan effort to modernize outdated FDA regulations for prescribing information, moving from paper-based delivery to electronic, which promises significant savings and improved efficiency for healthcare providers.